598,945 results on '"Pharmacology"'
Search Results
2. Intraperitoneal Paclitaxel-loaded TPM for Treatment of Peritoneal Carcinomatosis
3. Polso™ Watch Blood Pressure Accuracy With Blood Pressure Change Validation (BP)
4. Role of the ATP7A Transporter in Ovarian Cancer (ATHOC)
5. A Healthy Volunteer Safety Study of Pyronaridine Tetraphosphate Taken in Combination With Piperaquine Tetraphosphate
6. DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to D3 (Penta21)
7. PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY (PATHWAY-RCT)
8. Development of a Non-invasive Screening Tool to Predict NAFLD
9. Serological and PCR Testing for COVID-19
10. Educating Medical Students on How to Prescribe Anti-Hyperglycaemic Drugs: A Practical Guide
11. The EU Hyprotect Registry
12. Therapeutic drug monitoring to personalize dosing of imatinib, sunitinib, and pazopanib: A mixed methods study on barriers and facilitators
13. In patients with chronic heart failure which polypharmacy pheno-groups are associated with adverse health outcomes? (Polypharmacy pheno-groups and heart failure outcomes)
14. Atoguanil BA Study
15. Leveraging innovative technology to generate drug response phenotypes for the advancement of biomarker‐driven precision dosing
16. The Diabetes-Heart Disease Connection: Recent Discoveries and Implications
17. Sex and age differences in self-reported immune fitness
18. Vascular units as advanced living materials for bottom-up engineering of perfusable 3D microvascular networks
19. Towards consistency in dietary pattern scoring: standardising scoring workflows for healthy dietary patterns using 24-h recall and two variations of a food frequency questionnaire - CORRIGENDUM
20. Proceedings of the 12th Alcohol Hangover Research Group Meeting, in Buenos Aires, Argentina
21. Healthcare decision-making for tumour-agnostic therapies in Europe: lessons learned
22. The risk of delirium after sedation with propofol or midazolam in intensive care unit patients
23. Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort study
24. A blueprint for health technology assessment capacity building: lessons learned from Malta
25. Absenteeism, Presenteeism, and the Economic Costs of Alcohol Hangover in The Netherlands
26. A literature review of quality assessment and applicability to HTA of risk prediction models of coronary heart disease in patients with diabetes
27. Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate
28. Bayesian Optimization for the Inverse Problem in Electrocardiography
29. Methodology for biomarker discovery with reproducibility in microbiome data using machine learning
30. Fracture patterns and associated risk factors in pediatric and early adulthood type 1 diabetes: Findings from a nationwide retrospective cohort study
31. A robust microbiome signature for autism spectrum disorder across different studies using machine learning
32. Fracture patterns in adult onset type 1 diabetes and associated risk factors - A nationwide cohort study
33. Cost Savings and Waste Reduction Through Redispensing Unused Oral Anticancer Drugs: The ROAD Study
34. Epidemiological surveillance of drug safety using cumulative sequential analysis in electronic healthcare data
35. Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer
36. Cognitive processes in pharmacists’ clinical decision-making
37. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
38. Forging new paths in access to medicines research: Towards equitable access for all
39. Interplay of OATP1A/1B/2B1 uptake transporters and ABCB1 and ABCG2 efflux transporters in the handling of bilirubin and drugs
40. CRISPRing the way to Advanced in Vitro Modelling for Genetic Kidney Disease
41. Lifecycle HTA: Promising applications and a framework for implementation
42. Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review
43. Allergenic Shrimp Tropomyosin Distinguishes from a Non-Allergenic Chicken Homolog by Pronounced Intestinal Barrier Disruption and Downstream Th2 Responses in Epithelial and Dendritic Cell (Co)Culture
44. Impact of Drug Recalls on Patients in The Netherlands: A 5-Year Retrospective Data Analysis
45. A Nomogram to Predict Severe Toxicity in DPYD Wild-Type Patients Treated With Capecitabine-Based Anticancer Regimens
46. Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC Patients
47. The impact of scheduling ketamine as an internationally controlled substance on anaesthesia care in Sub-Saharan Africa: a case study and key informant interviews
48. ABCB1 attenuates brain exposure to the KRASG12C inhibitor opnurasib whereas binding to mouse carboxylesterase 1c influences its plasma exposure
49. Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous Administration
50. Buty and the beast: the complex role of butyrate in Parkinson’s disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.